期刊
SCANDINAVIAN JOURNAL OF IMMUNOLOGY
卷 -, 期 -, 页码 -出版社
WILEY
DOI: 10.1111/sji.13339
关键词
calcineurin inhibitor; in vitro; inflammation; microglia; oxidative stress; tacrolimus
类别
Microglial cells are crucial for the normal development and functioning of neurons in the central nervous system. They play a key role in maintaining brain homeostasis by monitoring the microenvironment for signs of injury or stress. This study investigated the potential of the FDA-approved calcineurin inhibitor Tacrolimus (FK506) to modulate microglial activation and reduce inflammation and oxidative stress. The findings suggest that FK506 could be a promising therapeutic agent for neurodegenerative diseases.
Microglial cells are indispensable for the normal development and functioning of neurons in the central nervous system, where they play a crucial role in maintaining brain homeostasis by surveilling the microenvironment for signs of injury or stress and responding accordingly. However, in neurodegenerative diseases, the density and phenotypes of microglial cells undergo changes, leading to chronic activation and inflammation. Shifting the focus from neurons to microglia in drug discovery for neurodegenerative diseases has become an important therapeutic target. This study was aimed to investigate the potential of Tacrolimus (FK506) an FDA-approved calcineurin inhibitor, to modulate the pathology of neurodegenerative diseases through anti-inflammatory and antioxidative effects on microglial activation. The human microglia clone 3 (HMC3) cells were exposed to 1 mu g/mL LPS in the presence and absence of doses of FK506. Survival rates of cells were determined using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) method. Morphological evaluation of cells showed that FK506 restored the normal morphology of activated microglia. Furthermore, FK506 treatment increases the total antioxidant capacity and reduces the total oxidative capacity, indicating its potential antioxidant effects. Data from ELISA and RT-PCR analyses showed that LPS abolished its promoting effects on the release of proinflammatory IL-1 beta and IL-6 cytokines in HMC3 cells, reflecting the anti-inflammatory effect of FK506. These findings support the idea that FK506 could be a promising therapeutic agent for neurodegenerative diseases by modulating microglial activation and reducing inflammation and oxidative stress.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据